Stocks
Themes
Market Cap Ranking
Trading Strategies
SEC Filings TLDR
Analysis Reports
Sign in
Loading stock data...
Loading updates and signals...
Back
ASNS
$0.55
-14.06%
Analyze
1M
+48.6%
3M
+5.8%
1Y
-58.3%
Market Cap:
$6.21M
Actelis Networks Inc.
Technology |
Communication Equipment
Arsanis, Inc., a clinical-stage biopharmaceutical company, focuses on applying monoclonal antibody (mAb) immunotherapies to treat infectious diseases. The company is headquartered in Waltham, Massachusetts.
Click "Analyze" to generate stock analysis
ASNS Price Trend and Signals
ASNS Financials
Signals
News
SEC Filings
Holders
Research Reports
AI Analysis
2025-10-28
Somewhat Bullish
macd_signal
Golden cross above zero detected.
2025-10-23
Bullish
price_signal
Large price change detected: 15.91%.
2025-10-17
Somewhat Bearish
macd_signal
Dead cross above zero detected.
2025-10-13
Bullish
price_signal
Large price change detected: 19.23%.